Impact of overlap on long-term clinical outcomes in patients undergoing everolimus-eluting bioresorbable vascular scaffolds implantation in routine clinical practice: insights from the European multicenter GHOST-EU registry

被引：1

作者：

Ortega-Paz, Luis ^{[1
]}

Giacchi, Giuseppe ^{[1
]}

Brugaletta, Salvatore ^{[1
]}

Sabate, Manel ^{[1
]}

Capodanno, Davide ^{[2
]}

Gori, Tommaso ^{[3
]}

Nef, Holger ^{[4
]}

Latib, Azeem ^{[5
]}

Mehilli, Julinda ^{[6
]}

Lesiak, Maciej ^{[7
]}

Caramanno, Giuseppe ^{[8
]}

Naber, Christoph ^{[9
]}

Di Mario, Carlo ^{[10
]}

Colombo, Antonio ^{[11
]}

Capranzano, Piera ^{[12
]}

Wiebe, Jens ^{[13
]}

Araszkiewicz, Aleksander ^{[14
]}

Geraci, Salvatore ^{[8
]}

Pyxaras, Stylianos A. ^{[15
]}

Mattesini, Alessio ^{[16
]}

Naganuma, Toru ^{[17
]}

Munzel, Thomas ^{[3
]}

Tamburino, Corrado ^{[2
]}

机构：

[1] IDIBAPS, Hosp Clin, Thorax Inst, Dept Cardiol, Barcelona, Spain

[2] Univ Catania, Catania, Italy

[3] Univ Med Ctr Mainz, Mainz, Germany

[4] Univ Giessen, D-35390 Giessen, Germany

[5] Univ Milan, Osped San Raffaele, I-20127 Milan, Italy

[6] Deutsch Herzzentrum Munich, Munich, Germany

[7] Poznan Univ Med Sci, Poznan, Poland

[8] San Giovanni di Dio Hosp, Agrigento, Italy

[9] Elisabeth Krankenhaus Essen, Contilia Heart & Vasc Ctr, Essen, Germany

[10] Univ London Imperial Coll Sci Technol & Med, London, England

[11] Hosp San Raffaele, EMO GVM Ctr Cuore Columbus, I-20132 Milan, Italy

[12] Univ Catania, Ferrarotto Hosp, Catania, Italy

[13] Univ Giessen, Med Klin 1, D-35390 Giessen, Germany

[14] Univ Med Sci, Dept Cardiol, Poznan, Poland

[15] Contilia Heart & Vasc Ctr, Essen, Germany

[16] Careggi Hosp, Florence, Italy

[17] New Tokyo Hosp, Matsudo, Chiba, Japan

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 66卷 / 15期

关键词：

Bioresorbable scaffold; Clinical outcomes; Percutaneous coronary intervention;

D O I：

10.1016/j.jacc.2015.08.056

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

TCT-12

引用

页码：B5 / B5

页数：1

共 41 条

[1] Impact of Overlapping on 1-Year Clinical Outcomes in Patients Undergoing Everolimus-Eluting Bioresorbable Scaffolds Implantation in Routine Clinical Practice: Insights from the European Multicenter GHOST-EU Registry
Ortega-Paz, Luis
Capodanno, Davide
Giacchi, Giuseppe
Gori, Tommaso
Nef, Holger
Latib, Azeem
Caramanno, Giuseppe
Di Mario, Carlo
Naber, Christoph
Lesiak, Maciej
Capranzano, Piera
Wiebe, Jens
Mehilli, Julinda
Araszkiewicz, Aleksander
Pyxaras, Stelios
Mattesini, Alessio
Geraci, Salvatore
Naganuma, Toru
Colombo, Antonio
Muenzel, Thomas
Sabate, Manel
Tamburino, Corrado
Brugaletta, Salvatore
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2017, 89 (05) : 812 - 818
[2] Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry
Capodanno, Davide
Gori, Tommaso
Nef, Holger
Latib, Azeem
Mehilli, Julinda
Lesiak, Maciej
Caramanno, Giuseppe
Naber, Christoph
Di Mario, Carlo
Colombo, Antonio
Capranzano, Piera
Wiebe, Jens
Araszkiewicz, Aleksander
Geraci, Salvatore
Pyxaras, Stelios
Mattesini, Alessio
Naganuma, Toru
Muenzel, Thomas
Tamburino, Corrado
EUROINTERVENTION, 2015, 10 (10) : 1144 - 1153
[3] Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions A Subanalysis of the International, Multicenter GHOST-EU Registry
Geraci, Salvatore
Kawamoto, Hiroyoshi
Caramanno, Giuseppe
Ruparelia, Neil
Capodanno, Davide
Brugaletta, Salvatore
Gori, Tommaso
Nef, Holger
Sabate, Manel
Mehilli, Julinda
Lesiak, Maciej
Naber, Christoph
Di Mario, Carlo
Capranzano, Piera
Wiebe, Jens
Araszkiewicz, Aleksander
Pyxaras, Stelios
Mattesini, Alessio
Muenzel, Thomas
Tamburino, Corrado
Colombo, Antonio
Latib, Azeem
JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (06) : 560 - 568
[4] Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry
Capranzano, Piera
Capodanno, Davide
Brugaletta, Salvatore
Latib, Azeem
Mehilli, Julinda
Nef, Holger
Gori, Tommaso
Lesiak, Maciej
Geraci, Salvatore
Pyxaras, Stelios
Mattesini, Alessio
Muenzel, Thomas
Araszkiewicz, Aleksander
Caramanno, Giuseppe
Naber, Christoph
Di Mario, Carlo
Sabate, Manel
Colombo, Antonio
Wiebe, Jens
Tamburino, Corrado
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 91 (03) : 444 - 453
[5] Long-Term Clinical Outcomes of Patients Treated With Everolimus-Eluting Bioresorbable Stents in Routine Practice 2-Year Results of the ISAR-ABSORB Registry
Wiebe, Jens
Hoppmann, Petra
Colleran, Roisin
Kufner, Sebastian
Valeskini, Michael
Cassese, Salvatore
Schneider, Simon
Joner, Michael
Schunkert, Heribert
Laugwitz, Karl-Ludwig
Kastrati, Adnan
Byrne, Robert A.
JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (12) : 1222 - 1229
[6] Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registry
Wiebe, Jens
Hoppmann, Petra
Kufner, Sebastian
Harada, Yukinori
Colleran, Roisin
Michel, Jonathan
Giacoppo, Daniele
Schneider, Simon
Cassese, Salvatore
Ibrahim, Tareq
Schunkert, Heribert
Laugwitz, Karl-Ludwig
Kastrati, Adnan
Byrne, Robert A.
EUROINTERVENTION, 2016, 12 (02) : E137 - E143
[7] Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold The BVS Expand Registry
Felix, Cordula M.
Fam, Jiang Ming
Diletti, Roberto
Ishibashi, Yuki
Karanasos, Antonios
Everaert, Bert R. C.
van Mieghem, Nicolas M. D. A.
Daemen, Joost
de Jaegere, Peter P. T.
Zijlstra, Felix
Regar, Evelyn S.
Onuma, Yoshinobu
van Geuns, Robert-Jan M.
JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (16) : 1652 - 1663
[8] Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry
Gori, Tommaso
Wiebe, Jens
Capodanno, Davide
Latib, Azeem
Lesiak, Maciej
Pyxaras, Stylianos A.
Mehilli, Julinda
Caramanno, Giuseppe
Di Mario, Carlo
Brugaletta, Salvatore
Weber, Julia
Capranzano, Piera
Sabate, Manel
Mattesini, Alessio
Geraci, Salvatore
Naber, Christoph K.
Araszkiewicz, Aleksander
Colombo, Antonio
Tamburino, Corrado
Nef, Holger
Muenzel, Thomas
EUROINTERVENTION, 2016, 12 (05) : E550 - E556
[9] Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial
Kerkmeijer, Laura S. M.
Renkens, Mick P. L.
Tijssen, Ruben Y. G.
Hofma, Sjoerd H.
van der Schaaf, Rene J.
Arkenbout, E. Karin
Weevers, Auke P. J. D.
Garcia-Garcia, Hector M.
Kraak, Robin
Piek, Jan J.
Tijssen, Jan G. P.
Henriques, Jose P. S.
de Winter, Robbert J.
Wykrzykowska, Joanna J.
EUROINTERVENTION, 2022, 17 (16) : 1340 - +
[10] Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice: Results of the ISAR-ABSORB registry
Hoppmann, P.
Kufner, S.
Cassese, S.
Wiebe, J.
Schneider, S.
Pinieck, S.
Scheler, L.
Bernlochner, I.
Joner, M.
Schunkert, H.
Laugwitz, K-L.
Kastrati, A.
Byrne, R. A.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 87 (05) : 822 - 829

← 1 2 3 4 5 →